Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsten Dahl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Psychoanalytic Study of the Child|May 2, 2003
In her mother's voice: reflections on "femininity" and the superegoE Kirsten Dahl
Diabetes, Obesity & Metabolism|July 2, 2021
Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et alKirsten Dahl, Tine A Baekdal
Acta Veterinaria Scandinavica. Supplementum|September 7, 2004
Rearing and caring for a future xenograft donor pigAxel Kornerup Hansen, Kirsten Dahl, Dorte Bratbo Sørensen
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 4, 2011
Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicityJohan F Paulsson, Marie-Odile Benoit-Biancamano, Lauge Schäffer, et al.
The Journal of Endocrinology|November 9, 2013
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivityKeld Fosgerau, Kirsten Raun, Cecilia Nilsson, et al.
Diabetologia|May 21, 2017
Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trialChristoph Kapitza, Kirsten Dahl, Jacob B Jacobsen, et al.
Acta Veterinaria Scandinavica. Supplementum|September 7, 2004
Xenotransplantation--state of the artAxel Kornerup Hansen, Kirsten Dahl, Dorte Bratbo Sørensen, et al.
Diabetes, Obesity & Metabolism|November 13, 2020
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetesCatherine Gibbons, John Blundell, Søren Tetens Hoff, et al.
The European Journal of Neuroscience|July 22, 2014
The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotypingFiona E Braegger, Lori Asarian, Kirsten Dahl, et al.
Diabetes, Obesity & Metabolism|March 12, 2021
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesKirsten Dahl, Ashley Brooks, Firas Almazedi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Psychoanalytic Study of the Child|May 2, 2003
In her mother's voice: reflections on "femininity" and the superegoE Kirsten Dahl
Diabetes, Obesity & Metabolism|July 2, 2021
Response to the letter from Horowitz et al. to the Editor relating to the publication 'Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes' by Dahl et alKirsten Dahl, Tine A Baekdal
Acta Veterinaria Scandinavica. Supplementum|September 7, 2004
Rearing and caring for a future xenograft donor pigAxel Kornerup Hansen, Kirsten Dahl, Dorte Bratbo Sørensen
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 4, 2011
Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicityJohan F Paulsson, Marie-Odile Benoit-Biancamano, Lauge Schäffer, et al.
The Journal of Endocrinology|November 9, 2013
Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivityKeld Fosgerau, Kirsten Raun, Cecilia Nilsson, et al.
Diabetologia|May 21, 2017
Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trialChristoph Kapitza, Kirsten Dahl, Jacob B Jacobsen, et al.
Acta Veterinaria Scandinavica. Supplementum|September 7, 2004
Xenotransplantation--state of the artAxel Kornerup Hansen, Kirsten Dahl, Dorte Bratbo Sørensen, et al.
Diabetes, Obesity & Metabolism|November 13, 2020
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetesCatherine Gibbons, John Blundell, Søren Tetens Hoff, et al.
The European Journal of Neuroscience|July 22, 2014
The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotypingFiona E Braegger, Lori Asarian, Kirsten Dahl, et al.
Diabetes, Obesity & Metabolism|March 12, 2021
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesKirsten Dahl, Ashley Brooks, Firas Almazedi, et al.
Pageof 3